Stay updated on Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe history list now includes a new revision entry: Revision: v3.4.2. The previously displayed funding-status notice and the v3.4.1 revision entry were removed.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a notice about government funding lapse and NIH operating status; updated the revision label from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedGlossary display was added; the page now color-codes changes with green for additions and red for deletions, and the revision footer includes No FEAR Act Data and Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedA new revision entry v3.3.4 was added to the Record History page, replacing the earlier v3.3.3 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedFooter updates show a new footer revision 'Revision: v3.3.3' added and the previous 'Revision: v3.3.2' entry along with the 'HHS Vulnerability Disclosure' link removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page history shows the addition of Revision: v3.3.2 and removal of Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.